Vanderbilt University Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Vanderbilt University Medical Center sits in the top decile of US sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count).

677 total trials 130 currently recruiting 400 completed early-phase tilt top decile by trial count

Vanderbilt University Medical Center: 677 sponsored US clinical trials, 130 recruiting.

Vanderbilt University Medical Center sponsors 677 registered US clinical trials on ClinicalTrials.gov, 130 of them currently recruiting, and 400 completed. 70 of these trials are in Phase 3-4 (later-stage) and 127 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autonomic Failure, with 9 trials.

Top-decile sponsor footprint

Vanderbilt University Medical Center ranks in the top decile of sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 54/100

400 of 467 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

677 total, page 11 of 14

COMPLETED NA

Pediatric Acute Kidney Injury (AKI) Retrospective, Real-Time and Repository Research

NCT02660931

COMPLETED

Assessment of Colonic Epithelial Integrity With Mucosal Impedance

NCT03165058

COMPLETED NA

Guanfacine for PONV and Pain After Sinus Surgery

NCT02882854

COMPLETED NA

Breathing Interventions for Relaxation: Dosing Through Extended Exhale

NCT02870868

COMPLETED Phase 4

Influenza Vaccine Feasibility Study in Children With Persistent Asthma

NCT02967393

COMPLETED Phase 4

Depressed Mood Improvement Through Nicotine Dosing (Depressed MIND Study)

NCT02816138

COMPLETED Phase 4

Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis

NCT03176966

COMPLETED NA

Bilateral Internal Jugular Veins Ultrasound Scanning Prior to CVC Placement

NCT02741453

COMPLETED Phase 1

Effect of Ghrelin on Glucose Metabolism After Bariatric Surgery

NCT02953587

TERMINATED NA

Auricular Acupuncture to Facilitate Outpatient Opioid Weaning

NCT02882048

COMPLETED Phase 2

Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)

NCT02784535

COMPLETED

The Impact of Quantitative Neuromuscular Monitoring in the PACU on Residual Blockade and Postoperative Recovery

NCT01933841

COMPLETED

Small Bowel Length and Bariatric Surgery Outcomes

NCT02872493

COMPLETED

Evaluating the Influence of Diabetes Stigma on Medication Adherence

NCT02828995

COMPLETED Phase 2

PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction

NCT02819440

COMPLETED NA

Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes

NCT02409329

COMPLETED NA

FAMS Mobile Health Intervention for Diabetes Self-care Support

NCT02481596

COMPLETED Phase 1

SinuSurf vs. Saline Solution in Normal Subjects

NCT02728505

COMPLETED Phase 3

Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.

NCT02809131

TERMINATED NA

Observation Versus Immediate Surgery of Low Risk Bladder Cancer

NCT02700724

COMPLETED NA

Early Postoperative Home Exercise Program After Cervical Spine Surgery

NCT02720172

TERMINATED Early Phase 1

Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure

NCT02591173

TERMINATED NA

Serial, Non-invasive Analysis of Exhaled Breath Condensate in Ventilated Trauma Patients

NCT02652247

COMPLETED

Mental Ability Challenge Study in Adults With and Without HIV

NCT03244488

COMPLETED NA

Surgical Site Infection With 0.05% Chlorhexidine (CHG) Compared to Triple Antibiotic Irrigation

NCT02395614

COMPLETED NA

Trial Evaluating Postop Pain and Muscle Strength Among Regional Anesthesia Techniques for Ambulatory ACL Reconstruction

NCT02584452

COMPLETED Phase 1

Role of the Foregut in Nutrient Metabolism in Lean and Obese Humans

NCT02537314

COMPLETED NA

Comparison of Mask Ventilation Techniques in Patients Requiring General Anesthesia

NCT02580526

COMPLETED

Treatment Alternatives in iSGS (NoAAC PR-02 Study)

NCT02481817

COMPLETED Phase 2

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

NCT02312934

COMPLETED NA

Reduced Opioid Analgesic Requirements Via Improved Endogenous Opioid Function

NCT02469077

COMPLETED NA

Bowel Preparation Quality for Screening Colonoscopy

NCT02690779

COMPLETED NA

End-Stage Renal Disease Intra-dialysis Lifestyle Education Study

NCT02361268

TERMINATED NA

New Tools for Assessing Fracture Risk

NCT02436356

COMPLETED Phase 2

Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy)

NCT02463409

TERMINATED NA

Non-invasive Versus Invasive Blood Pressure Measurement in the Morbidly Obese Parturient With Severe Preeclampsia

NCT03222414

COMPLETED Phase 4

Connectivity Affecting the Antidepressant REsponse Study

NCT02332291

COMPLETED NA

Mindfulness Training and Parent-coaching Interventions for Autism Spectrum Disorder

NCT03889821

COMPLETED

Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2

NCT02526485

COMPLETED Phase 1

Racial Differences in Vagal Control of Glucose Homeostasis

NCT02365285

COMPLETED

Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism

NCT02411461

COMPLETED NA

Increasing Minority Participation in Clinical Trials

NCT02600533

TERMINATED NA

Sleep Position May Reduce Acid Reflux Symptoms at Night

NCT02320968

COMPLETED NA

Safety and Efficacy of Laryngeal Mask Airways in Sinonasal Surgery

NCT02311153

COMPLETED

Prospective Observation of Cardiac Safety With Proteasome Inhibition

NCT02178579

COMPLETED NA

Study to Compare the Incidence of Biliary Complications After Liver Transplantation

NCT03165916

COMPLETED NA

Magnesium Treatment on Vitamin D Metabolism in Participants Completed Personalized Prevention of Colorectal Cancer Trial

NCT03265483

COMPLETED

Mucosal Impedance in Pediatric Population

NCT02320981

COMPLETED

Testing Tissue Sodium Stores in CAPD Patients-Aims 1 & 2

NCT02212327

COMPLETED NA

Postoperative Management for Degenerative Spinal Conditions

NCT02184143

← Previous Page 11 of 14 Next →

Phase Distribution

PhaseTrial count
Phase 1 65
Phase 2 62
Phase 3 14
Phase 4 56

What is open in the Vanderbilt University Medical Center pipeline

130 recruiting of 677 indexed (19% open); 400 completed (59%).

Phase mix: 70 late (III/IV) vs 127 early (I/II) (early-phase heavy).

Top condition: Autonomic Failure (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Vanderbilt University Medical Center: open-pipeline peers nationwide

Peers matched on 677 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01,0002,0003,000 12%14%16%18%20%22%24% Total trials Recruiting share Vanderbilt University Medical CenterThe Cleveland ClinicUniversity of California, DavisWeill Medical College of Cornell UniversityIcahn School of Medicine at Mount SinaiCalifornia Polytechnic State University-San Luis ObispoPhoenix Children's HospitalMayo ClinicUniversity of South Carolina
Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 677 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this Vanderbilt University Medical Center page

677 registered trials is a research-attention snapshot, not an endorsement of Vanderbilt University Medical Center or any single study.

  • 130 of Vanderbilt University Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Autonomic Failure is the condition Vanderbilt University Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autonomic Failure trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Vanderbilt University Medical Center pipeline card: 677 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.